Cannabix Technologies Makes Advances with Marijuana Breathalyzer Development and THC Breath Capture
UF startup Cannabix Technologies Inc., developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that... Read More
SharpSpring Recognized with Three Major Industry Awards in Less than One Month
UF startup SharpSpring, Inc., a leading cloud-based marketing automation platform, announced it has been recognized with its third industry award in as... Read More
Leading Medical Physics Meeting to Feature More than 40 Presentations on ViewRay’s MRIdian MRI-Guided Radiotherapy
UF startup ViewRay, Inc., a company dedicated to giving clinicians new and better ways to treat cancer with radiation therapy, announced that... Read More
SharpSpring Unveils Sales Optimizer, a First-of-Its-Kind Product to Streamline the Sales Process
UF startup SharpSpring, Inc., a leading cloud-based marketing automation platform, announced the release of Sales Optimizer, a suite of tools that allows... Read More
National Science Foundation Awards TAO Connect $500K Grant to Develop and Launch Its AI-Based Chatbot
UF startup TAO Connect, a digital health company aiming to make behavioral health therapy more accessible and efficient, announced it has received... Read More
SharpSpring Recognized As “Top Rated All-in-One Marketing Tool for 2019” by TrustRadius
UF startup SharpSpring, Inc., a leading cloud-based marketing automation platform, announced it has been recognized as a Top Rated All-in-One Marketing Tool... Read More
Algernon Pharmaceuticals’ NP-120 Reduced Fibrosis in an Idiopathic Pulmonary Fibrosis Study by 56 Percent
Algernon Pharmaceuticals Inc., formerly known as Breathtec, a UF startup, announced that NP-120, its repurposed lead candidate for the treatment of idiopathic... Read More
Oxthera Presents Continuous Strong Data from an Interim Analysis of Its Phase 2 Study with Oxabact in Primary Hyperoxaluria
UF startup OxThera AB, a privately-held Stockholm-based biopharmaceutical company dedicated to improving the lives of people living with Primary Hyperoxaluria (PH), announced... Read More
OxThera Initiates Extension Part of a Phase 3 Study of Oxabact in Primary Hyperoxaluria
UF startup OxThera AB, a privately-held Stockholm-based biopharmaceutical company dedicated to improving the lives of people living with Primary Hyperoxaluria, announced that... Read More
Clinipace’s Data Aggregation Solution Will Be Showcased at DIA Annual Meeting
UF startup Clinipace, a global full-service contract research organization (CRO), will showcase Clarity Stack® clinical technology at the 2019 Drug Information Association... Read More
